New Zealand markets closed

Bristol-Myers Squibb Company (BMY)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
57.60-0.21 (-0.36%)
At close: 4:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
44,384,000
42,518,000
26,145,000
22,561,000
20,776,000
Cost of revenue
10,705,000
11,773,000
8,078,000
6,547,000
6,066,000
Gross profit
33,679,000
30,745,000
18,067,000
16,014,000
14,710,000
Operating expenses
Research development
11,745,000
11,143,000
6,148,000
6,345,000
6,411,000
Selling general and administrative
7,975,000
7,661,000
4,871,000
4,551,000
4,849,000
Total operating expenses
30,175,000
29,098,000
12,455,000
11,027,000
11,553,000
Operating income or loss
3,504,000
1,647,000
5,612,000
4,987,000
3,157,000
Interest expense
1,384,000
1,420,000
656,000
183,000
196,000
Total other income/expenses net
-6,231,000
-7,098,000
19,000
1,164,000
2,170,000
Income before tax
-4,111,000
-6,871,000
4,975,000
5,968,000
5,131,000
Income tax expense
948,000
2,124,000
1,515,000
1,021,000
4,156,000
Income from continuing operations
-5,059,000
-8,995,000
3,460,000
4,947,000
975,000
Net income
-5,079,000
-9,015,000
3,439,000
4,920,000
1,007,000
Net income available to common shareholders
-5,079,000
-9,015,000
3,439,000
4,920,000
1,007,000
Basic EPS
-
-3.99
2.02
3.03
0.61
Diluted EPS
-
-3.99
2.01
3.03
0.61
Basic average shares
-
2,258,000
1,705,000
1,633,000
1,645,000
Diluted average shares
-
2,258,000
1,712,000
1,637,000
1,652,000
EBITDA
-
4,929,000
7,377,000
6,788,000
6,116,000